Bluefin Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bluefin Capital Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-105,600	Closed	-$341K	–	798
2019 Q3	$341K	Buy	+105,600	New	+$10.6M	0.05%	216

Bluefin Capital Management's ONCE Position: Q3 2019 in Review

Bluefin Capital Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 2,994 shares — an estimated $300K sold.

Bluefin Capital Management first reported a position in ONCE in Q2 2019 and held it in 1 quarter. The position peaked at $307K in Q2 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

Bluefin Capital Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Bluefin Capital Management sold 2,994 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $300K.
Bluefin Capital Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
Bluefin Capital Management's Spark Therapeutics, Inc. Common Stock position peaked at $307K in Q2 2019.
184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Bluefin Capital Management's 13F filing for Q3 2019, filed 15 Nov 2019.